What is Coloplast?
Coloplast is a medical device company company serving enterprise, commercial, consumer, healthcare, financial, real estate, or regulated-market customers.
- Category
- Medical device company
- Headquarters
- Humlebaek, Denmark
- Founded
- See official company history
- Employees
- See latest annual report and company filings
- Total funding
- Public company
- Status
- Public company; Nasdaq Copenhagen: COLO B
What is Coloplast?
Coloplast is a medical device company company headquartered in Humlebaek, Denmark. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
Coloplast is a medical device company company headquartered in Humlebaek, Denmark. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
For sellers, Coloplast should be mapped as a scaled public-company account. The best timing signals are earnings commentary, capital spending, hiring clusters, product launches, acquisitions, facility investments, and leadership changes.
What does Coloplast offer?
Coloplast's profile centers on Ostomy care, Continence care, Wound care, Interventional urology.
- Ostomy care· Medical device company
- Continence care· Medical device company
- Wound care· Medical device company
- Interventional urology· Medical device company
- Medical devices· Medical device company
- Healthcare services· Medical device company
How does Coloplast make money?
Coloplast makes money through commercial activity tied to medical device company.
Coloplast monetizes through the model common to medical device company: product sales, recurring services, contracts, leases, subscriptions, transaction volume, servicing, investment management, or usage depending on the operating unit.
Sales angles should connect to measurable priorities such as margin, growth, occupancy, compliance, retention, automation, risk reduction, data quality, customer experience, or field productivity.
Who leads Coloplast?
Coloplast's named executives should be verified on the official leadership or investor-relations page before outreach.
- Coloplast executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- Coloplast finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
- Coloplast operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.
How do you contact Coloplast's leadership?
Coloplast should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://www.coloplast.com- Coloplast investor relationsInvestor relations / corporate contactcontact via https://www.coloplast.com
How is Coloplast funded?
Coloplast's current status is Public company; Nasdaq Copenhagen: COLO B.
Coloplast's capital profile is best understood through its current public-company status: Public company; Nasdaq Copenhagen: COLO B. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capital expenditure plans, and management commentary rather than venture funding rounds.
Before outreach, verify the latest status on the company's investor-relations page and current exchange filings.
How did Coloplast get here?
Coloplast's history should be read through founding, scale-up, public-market ownership, and current product or market focus.
- FoundingColoplast is foundedThe company begins building in medical device company.
- Scale-upCommercial footprint expandsColoplast broadens its product, customer, distribution, or geographic reach.
- Public marketsPublic company; Nasdaq Copenhagen: COLO BPublic-company ownership shapes reporting, procurement, and operating priorities.
- 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.
Who are Coloplast's competitors?
Coloplast competes with larger incumbents and focused specialists in medical device company.
Coloplast — frequently asked questions
